bone resorption Search Results


94
Cosmo Bio USA bone resorption assay kit
Bone Resorption Assay Kit, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc09329329-79-1-5?v=Cosmo+Bio+USA
Average 94 stars, based on 1 article reviews
bone resorption assay kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Cosmo Bio USA bone resorption assay plate 24
Bone Resorption Assay Plate 24, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc06089868-101-11-16?v=Cosmo+Bio+USA
Average 93 stars, based on 1 article reviews
bone resorption assay plate 24 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Corning Life Sciences osteo assay surface for bone resorption
Osteo Assay Surface For Bone Resorption, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc04746671-159-5-10?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
osteo assay surface for bone resorption - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Osteometer MediTech serum bone resorption marker c-telopeptide
Serum Bone Resorption Marker C Telopeptide, supplied by Osteometer MediTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/10__1111_slash_jbmr__1999__14__s1__1-294-9-14?v=Osteometer+MediTech
Average 90 stars, based on 1 article reviews
serum bone resorption marker c-telopeptide - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Corning Life Sciences bone resorption plate covered with hydroxy-limestone
Bone Resorption Plate Covered With Hydroxy Limestone, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pm36132487-48-28-29?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
bone resorption plate covered with hydroxy-limestone - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Corning Life Sciences bone resorption pits on corning osteoassay 24-well plates
EPO enhances RANKL-induced osteoclast differentiation and bone <t>resorption</t> in vitro. (A) Representative TRAP staining images of BMMs treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO and EMP9. Scale bar = 200 μm. (B) Representative images of osteoclasts with actin ring (red) and cell nucleus (blue); the BMMs were treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO or/and EMP9. Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates. Scale bar = 200 μm. (D) The area of TRAP + multinucleated cells (nuclei > 3) was quantified in each group. (E) The relative cell size of TRAP + multinuclear cells (nuclei > 3) was quantified in each group. (F) EPO increased the number of multinucleated cells (nuclei > 3) with actin rings. (G) The relative resorption area was quantified by using ImageJ Software. Error bars are mean ± SD of triplicate experiments; * P < 0.05; ** P < 0.01; *** P < 0.001; NS, not significant
Bone Resorption Pits On Corning Osteoassay 24 Well Plates, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc11403934-94-9-13?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
bone resorption pits on corning osteoassay 24-well plates - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
International Federation of Clinical Chemistry and Laboratory Medicine reference markers of bone resorption and formation
EPO enhances RANKL-induced osteoclast differentiation and bone <t>resorption</t> in vitro. (A) Representative TRAP staining images of BMMs treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO and EMP9. Scale bar = 200 μm. (B) Representative images of osteoclasts with actin ring (red) and cell nucleus (blue); the BMMs were treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO or/and EMP9. Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates. Scale bar = 200 μm. (D) The area of TRAP + multinucleated cells (nuclei > 3) was quantified in each group. (E) The relative cell size of TRAP + multinuclear cells (nuclei > 3) was quantified in each group. (F) EPO increased the number of multinucleated cells (nuclei > 3) with actin rings. (G) The relative resorption area was quantified by using ImageJ Software. Error bars are mean ± SD of triplicate experiments; * P < 0.05; ** P < 0.01; *** P < 0.001; NS, not significant
Reference Markers Of Bone Resorption And Formation, supplied by International Federation of Clinical Chemistry and Laboratory Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc08166738-41-14-43?v=International+Federation+of+Clinical+Chemistry+and+Laboratory+Medicine
Average 90 stars, based on 1 article reviews
reference markers of bone resorption and formation - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology ctx/c-telopeptide assay for bone resorption
The double deletion of Ctsk and Mmp9 impairs osteoclast function in vitro . ( a ) TRAP staining shows decreased OC formation in MBM cells isolated from Mmp9 -/- ,Ctsk -/- and Ctsk -/- / Mmp9 -/- cells that were stimulated by M-CSF and RANKL for 5 days. Higher magnification images are shown in the lower panels. (b) MBM cells isolated from WT, Ctsk -/- , Mmp9 -/- , or Ctsk -/- / Mmp9 -/- mice and then treated with M-CSF and RANKL for 5 days to promote OC differentiation. (b, Top panel) Acridine orange staining revealed that extracellular acidity (red-orange) was significantly reduced in DKO cells. (b, Bottom panel) F-actin ring formation assay for cell cultures shows disrupted or absent ringed structures of F-actin dots (actin rings) in Ctsk -/- /Mmp9 -/- and Ctsk -/- mice. Inset is the magnified image of the boxed areas. (c) Quantification for panels A and B (n=5 independent experiments). (d) Pre-OC seeded on bone slices were cultured with M-CSF and RANKL for 6 days before being submitted to bone <t>resorption</t> analysis. WGA-FITC staining revealed a drastic decreased in bone resorption in Ctsk -/- OCs and a near absence of bone resorption in Ctsk -/- Mmp9 -/- OCs, but Mmp9 -/- and WT cells showed similar bone resorption abilitie©( e ) Quantification for D is shown (n>20, Pit depth). All the data are presented as mean values ± SD; two-tailed unpaired t test; ns. non-significant.
Ctx/C Telopeptide Assay For Bone Resorption, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc09461675-54-7-9?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
ctx/c-telopeptide assay for bone resorption - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA 48-well bone resorption assay plate
Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and <t>resorption</t> activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.
48 Well Bone Resorption Assay Plate, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc07064362-49-2-10?v=Cosmo+Bio+USA
Average 90 stars, based on 1 article reviews
48-well bone resorption assay plate - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA bone osteoclastic resorption activity
Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and <t>resorption</t> activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.
Bone Osteoclastic Resorption Activity, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pm23030062-108-6-4?v=Cosmo+Bio+USA
Average 90 stars, based on 1 article reviews
bone osteoclastic resorption activity - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Ostex International biochemical markers of bone resorption n-terminal telopeptides
Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and <t>resorption</t> activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.
Biochemical Markers Of Bone Resorption N Terminal Telopeptides, supplied by Ostex International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pm17146025-74-30-34?v=Ostex+International
Average 90 stars, based on 1 article reviews
biochemical markers of bone resorption n-terminal telopeptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Esoterix Genetic Laboratories ctx bone resorption marker
Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and <t>resorption</t> activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.
Ctx Bone Resorption Marker, supplied by Esoterix Genetic Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bone+resorption/pmc06619388-125-0-4?v=Esoterix+Genetic+Laboratories
Average 90 stars, based on 1 article reviews
ctx bone resorption marker - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


EPO enhances RANKL-induced osteoclast differentiation and bone resorption in vitro. (A) Representative TRAP staining images of BMMs treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO and EMP9. Scale bar = 200 μm. (B) Representative images of osteoclasts with actin ring (red) and cell nucleus (blue); the BMMs were treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO or/and EMP9. Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates. Scale bar = 200 μm. (D) The area of TRAP + multinucleated cells (nuclei > 3) was quantified in each group. (E) The relative cell size of TRAP + multinuclear cells (nuclei > 3) was quantified in each group. (F) EPO increased the number of multinucleated cells (nuclei > 3) with actin rings. (G) The relative resorption area was quantified by using ImageJ Software. Error bars are mean ± SD of triplicate experiments; * P < 0.05; ** P < 0.01; *** P < 0.001; NS, not significant

Journal: Molecular Medicine

Article Title: Erythropoietin regulates osteoclast formation via up-regulating PPARγ expression

doi: 10.1186/s10020-024-00931-7

Figure Lengend Snippet: EPO enhances RANKL-induced osteoclast differentiation and bone resorption in vitro. (A) Representative TRAP staining images of BMMs treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO and EMP9. Scale bar = 200 μm. (B) Representative images of osteoclasts with actin ring (red) and cell nucleus (blue); the BMMs were treated with 30 ng/mL M-CSF and 50 ng/mL RANKL for four days in the presence of EPO or/and EMP9. Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates. Scale bar = 200 μm. (D) The area of TRAP + multinucleated cells (nuclei > 3) was quantified in each group. (E) The relative cell size of TRAP + multinuclear cells (nuclei > 3) was quantified in each group. (F) EPO increased the number of multinucleated cells (nuclei > 3) with actin rings. (G) The relative resorption area was quantified by using ImageJ Software. Error bars are mean ± SD of triplicate experiments; * P < 0.05; ** P < 0.01; *** P < 0.001; NS, not significant

Article Snippet: Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates.

Techniques: In Vitro, Staining, Software

EPO binding to its receptor EPOR activates the Jak2/ERK signal pathway, increasing PPARγ expression. Then, PPARγ directly regulated the expression of c-fos to promote osteoclast differentiation and enhanced osteoclastic bone resorption

Journal: Molecular Medicine

Article Title: Erythropoietin regulates osteoclast formation via up-regulating PPARγ expression

doi: 10.1186/s10020-024-00931-7

Figure Lengend Snippet: EPO binding to its receptor EPOR activates the Jak2/ERK signal pathway, increasing PPARγ expression. Then, PPARγ directly regulated the expression of c-fos to promote osteoclast differentiation and enhanced osteoclastic bone resorption

Article Snippet: Scale bar = 200 μm. (C) Representative images of bone resorption pits on Corning Osteoassay 24-well plates.

Techniques: Binding Assay, Expressing

The double deletion of Ctsk and Mmp9 impairs osteoclast function in vitro . ( a ) TRAP staining shows decreased OC formation in MBM cells isolated from Mmp9 -/- ,Ctsk -/- and Ctsk -/- / Mmp9 -/- cells that were stimulated by M-CSF and RANKL for 5 days. Higher magnification images are shown in the lower panels. (b) MBM cells isolated from WT, Ctsk -/- , Mmp9 -/- , or Ctsk -/- / Mmp9 -/- mice and then treated with M-CSF and RANKL for 5 days to promote OC differentiation. (b, Top panel) Acridine orange staining revealed that extracellular acidity (red-orange) was significantly reduced in DKO cells. (b, Bottom panel) F-actin ring formation assay for cell cultures shows disrupted or absent ringed structures of F-actin dots (actin rings) in Ctsk -/- /Mmp9 -/- and Ctsk -/- mice. Inset is the magnified image of the boxed areas. (c) Quantification for panels A and B (n=5 independent experiments). (d) Pre-OC seeded on bone slices were cultured with M-CSF and RANKL for 6 days before being submitted to bone resorption analysis. WGA-FITC staining revealed a drastic decreased in bone resorption in Ctsk -/- OCs and a near absence of bone resorption in Ctsk -/- Mmp9 -/- OCs, but Mmp9 -/- and WT cells showed similar bone resorption abilitie©( e ) Quantification for D is shown (n>20, Pit depth). All the data are presented as mean values ± SD; two-tailed unpaired t test; ns. non-significant.

Journal: International Journal of Biological Sciences

Article Title: Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis

doi: 10.7150/ijbs.72211

Figure Lengend Snippet: The double deletion of Ctsk and Mmp9 impairs osteoclast function in vitro . ( a ) TRAP staining shows decreased OC formation in MBM cells isolated from Mmp9 -/- ,Ctsk -/- and Ctsk -/- / Mmp9 -/- cells that were stimulated by M-CSF and RANKL for 5 days. Higher magnification images are shown in the lower panels. (b) MBM cells isolated from WT, Ctsk -/- , Mmp9 -/- , or Ctsk -/- / Mmp9 -/- mice and then treated with M-CSF and RANKL for 5 days to promote OC differentiation. (b, Top panel) Acridine orange staining revealed that extracellular acidity (red-orange) was significantly reduced in DKO cells. (b, Bottom panel) F-actin ring formation assay for cell cultures shows disrupted or absent ringed structures of F-actin dots (actin rings) in Ctsk -/- /Mmp9 -/- and Ctsk -/- mice. Inset is the magnified image of the boxed areas. (c) Quantification for panels A and B (n=5 independent experiments). (d) Pre-OC seeded on bone slices were cultured with M-CSF and RANKL for 6 days before being submitted to bone resorption analysis. WGA-FITC staining revealed a drastic decreased in bone resorption in Ctsk -/- OCs and a near absence of bone resorption in Ctsk -/- Mmp9 -/- OCs, but Mmp9 -/- and WT cells showed similar bone resorption abilitie©( e ) Quantification for D is shown (n>20, Pit depth). All the data are presented as mean values ± SD; two-tailed unpaired t test; ns. non-significant.

Article Snippet: ELISA kits used were CTX/C-telopeptide assay for bone resorption (MyBioSource, cat# MBS724196), P1NP/total procollagen type 1 N-terminal propeptide (R&D Systems, cat# DY6220-05).

Techniques: In Vitro, Staining, Isolation, Tube Formation Assay, Cell Culture, Two Tailed Test

Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and resorption activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.

Journal: Journal of Bone Metabolism

Article Title: Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38- and Ca 2+ -Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression

doi: 10.11005/jbm.2020.27.1.53

Figure Lengend Snippet: Effect of Rosae Multiflorae fructus extract (RMF-E) on osteoclast differentiation and resorption activity. Bone marrow-derived macrophages were cultured with the indicated concentrations of RMF-E, under receptor activator of nuclear factor-κB ligand (100 ng/mL) and macrophage-colony stimulating factor (30 ng/mL) treatment, for 4 days. (A) Osteoclasts were fixed and stained for tartrate-resistant acid phosphatase (TRAP). (B) TRAP + -multinuclear cells with ≥3 nuclei were counted as mature osteoclasts. (C) Total TRAP activity from TRAP + -mono-, di-, and multi-nuclear cells were measured at an absorbance of 405 nm (A 405 nm ). (D) F-actin rings were stained with rhodamine-phalloidin in osteoclasts treated with/without RMF-E (20 µg/mL). (E) The resorption activity of osteoclasts treated with/without RMF-E (20 µg/mL) was measured by pit formation on hydroxyapatite-coated plates, after 7 days. Data are expressed as the mean±standard deviation and are representative of 3 independent experiments. * P <0.05, ** P <0.01, and *** P <0.001 vs. the non-treated control (NC, 0 µg/mL RMF-E) (Scale bar=200 µm). NS, not significant.

Article Snippet: To measure bone resorption activity, BMMs were cultured in a Cosmo Bio 48-well bone resorption assay plate (Oriental Yeast Co., Ltd., Tokyo, Japan) under M-CSF and RANKL treatment with/without RMF-E (20 μg/mL) for 7 days, and then cleared using bleach.

Techniques: Activity Assay, Derivative Assay, Cell Culture, Staining, Standard Deviation, Control